Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)
CNY 5.99
(2.92%)
CNY 5.99
(2.92%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 373.52 Million CNY | -1.3% |
| 2022 | 424.22 Million CNY | -20.57% |
| 2021 | 534.08 Million CNY | -3.04% |
| 2020 | 550.85 Million CNY | -2.39% |
| 2019 | 564.35 Million CNY | 38.45% |
| 2018 | 407.62 Million CNY | 19.77% |
| 2017 | 340.32 Million CNY | -1.18% |
| 2016 | 344.4 Million CNY | -4.41% |
| 2015 | 360.3 Million CNY | 12.69% |
| 2014 | 319.72 Million CNY | 35.12% |
| 2013 | 236.62 Million CNY | 16.36% |
| 2012 | 203.35 Million CNY | 38.48% |
| 2011 | 146.85 Million CNY | 37.63% |
| 2010 | 106.7 Million CNY | 21.75% |
| 2009 | 87.63 Million CNY | 18.2% |
| 2008 | 74.14 Million CNY | 20.61% |
| 2007 | 61.47 Million CNY | 38.98% |
| 2006 | 44.23 Million CNY | 23.65% |
| 2005 | 35.77 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 113.08 Million CNY | -2.01% |
| 2024 Q3 | 124.77 Million CNY | 10.34% |
| 2024 Q1 | 115.4 Million CNY | 14.52% |
| 2023 Q3 | 100.95 Million CNY | -20.75% |
| 2023 Q4 | 100.76 Million CNY | -0.19% |
| 2023 FY | 418.7 Million CNY | -1.3% |
| 2023 Q1 | 89.58 Million CNY | -6.91% |
| 2023 Q2 | 127.39 Million CNY | 42.21% |
| 2022 Q3 | 119.3 Million CNY | 21.9% |
| 2022 FY | 424.22 Million CNY | -20.57% |
| 2022 Q2 | 97.86 Million CNY | -11.69% |
| 2022 Q4 | 96.23 Million CNY | -19.33% |
| 2022 Q1 | 110.82 Million CNY | 18.32% |
| 2021 Q2 | 200.22 Million CNY | 44.0% |
| 2021 Q1 | 139.04 Million CNY | 1.24% |
| 2021 Q4 | 93.65 Million CNY | -7.41% |
| 2021 Q3 | 101.15 Million CNY | -49.48% |
| 2021 FY | 534.08 Million CNY | -3.04% |
| 2020 FY | 550.85 Million CNY | -2.39% |
| 2020 Q2 | 157.77 Million CNY | 87.26% |
| 2020 Q3 | 171.49 Million CNY | 8.69% |
| 2020 Q4 | 137.33 Million CNY | -19.92% |
| 2020 Q1 | 84.25 Million CNY | -41.26% |
| 2019 Q2 | 159.23 Million CNY | 36.0% |
| 2019 FY | 564.35 Million CNY | 38.45% |
| 2019 Q4 | 143.42 Million CNY | -0.82% |
| 2019 Q3 | 144.61 Million CNY | -9.18% |
| 2019 Q1 | 117.08 Million CNY | 23.9% |
| 2018 FY | 407.62 Million CNY | 19.77% |
| 2018 Q3 | 103.44 Million CNY | -18.49% |
| 2018 Q1 | 82.78 Million CNY | 20.78% |
| 2018 Q4 | 94.49 Million CNY | -8.65% |
| 2018 Q2 | 126.9 Million CNY | 53.3% |
| 2017 Q4 | 68.53 Million CNY | -24.5% |
| 2017 FY | 340.32 Million CNY | -1.18% |
| 2017 Q2 | 106.4 Million CNY | 42.61% |
| 2017 Q1 | 74.6 Million CNY | 16.58% |
| 2017 Q3 | 90.78 Million CNY | -14.68% |
| 2016 Q1 | 82.9 Million CNY | 21.21% |
| 2016 Q3 | 88.68 Million CNY | -18.51% |
| 2016 Q2 | 108.81 Million CNY | 31.25% |
| 2016 Q4 | 63.99 Million CNY | -27.83% |
| 2016 FY | 344.4 Million CNY | -4.41% |
| 2015 Q3 | 90.94 Million CNY | -20.79% |
| 2015 FY | 360.3 Million CNY | 12.69% |
| 2015 Q2 | 114.81 Million CNY | 33.3% |
| 2015 Q4 | 68.4 Million CNY | -24.79% |
| 2015 Q1 | 86.13 Million CNY | -25.49% |
| 2014 Q4 | 115.59 Million CNY | 62.22% |
| 2014 Q1 | 56.18 Million CNY | -19.7% |
| 2014 Q2 | 76.68 Million CNY | 36.49% |
| 2014 FY | 319.72 Million CNY | 35.12% |
| 2014 Q3 | 71.26 Million CNY | -7.07% |
| 2013 FY | 236.62 Million CNY | 16.36% |
| 2013 Q4 | 69.96 Million CNY | 16.12% |
| 2013 Q1 | 47.91 Million CNY | -10.34% |
| 2013 Q2 | 58.49 Million CNY | 22.09% |
| 2013 Q3 | 60.25 Million CNY | 3.01% |
| 2012 Q3 | 55.09 Million CNY | 1.96% |
| 2012 FY | 203.35 Million CNY | 38.48% |
| 2012 Q4 | 53.43 Million CNY | -3.0% |
| 2012 Q2 | 54.03 Million CNY | 32.45% |
| 2012 Q1 | 40.79 Million CNY | 0.52% |
| 2011 Q3 | 39.6 Million CNY | 5.35% |
| 2011 Q2 | 37.58 Million CNY | 29.26% |
| 2011 FY | 146.85 Million CNY | 37.63% |
| 2011 Q1 | 29.07 Million CNY | 6.46% |
| 2011 Q4 | 40.58 Million CNY | 2.49% |
| 2010 Q1 | 23.6 Million CNY | 9.81% |
| 2010 Q2 | 26.95 Million CNY | 14.19% |
| 2010 Q3 | 28.83 Million CNY | 6.98% |
| 2010 FY | 106.7 Million CNY | 21.75% |
| 2010 Q4 | 27.31 Million CNY | -5.27% |
| 2009 Q4 | 21.49 Million CNY | -10.27% |
| 2009 Q2 | 23.48 Million CNY | 25.53% |
| 2009 Q1 | 18.7 Million CNY | -3.87% |
| 2009 FY | 87.63 Million CNY | 18.2% |
| 2009 Q3 | 23.95 Million CNY | 1.99% |
| 2008 Q3 | 19.15 Million CNY | 0.0% |
| 2008 Q4 | 19.46 Million CNY | 1.58% |
| 2008 FY | 74.14 Million CNY | 20.61% |
| 2007 FY | 61.47 Million CNY | 38.98% |
| 2006 FY | 44.23 Million CNY | 23.65% |
| 2005 FY | 35.77 Million CNY | 0.0% |